Results from a phase I study of 4- <i>l</i>-[131I]iodo-phenylalanine ([ <sup>131</sup>I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).

Auteurs

Pichler J, Traub-Weidinger T, Spiegl K, Imamovic L, Braat AJAT, Snijders TJ, Verhoeff JJC, Flamen P, Tauchmanova L, Hayward C, Kluge A

  • Date de publication

    January 2024

  • Type

    Article

  • Review

    Neurooncol Adv

  • Researcher's name

    FLAMEN PATRICK

  • Hôpital

    Institut Jules Bordet

  • Service

    Médecine nucléaire IJB

  • PMID

    39211520

  • DOI

    10.1093/noajnl/vdae130